Tamoxifen: Dr. Jekyll and Mr. Hyde? [electronic resource]
Producer: 20040624Description: 895-7 p. digitalISSN:- 1460-2105
- Antibodies, Monoclonal -- pharmacology
- Antibodies, Monoclonal, Humanized
- Antineoplastic Agents, Hormonal -- adverse effects
- Aromatase Inhibitors
- Breast Neoplasms -- chemistry
- Carcinoma, Ductal, Breast -- chemistry
- Chemotherapy, Adjuvant
- Clinical Trials as Topic
- Drug Resistance, Neoplasm
- Enzyme Inhibitors -- pharmacology
- Epidermal Growth Factor -- antagonists & inhibitors
- Female
- Gefitinib
- Humans
- Neoplasms, Hormone-Dependent -- drug therapy
- Phosphorylation
- Quinazolines -- pharmacology
- Receptor Cross-Talk
- Receptor, ErbB-2 -- metabolism
- Receptors, Estrogen -- metabolism
- Retrospective Studies
- Selective Estrogen Receptor Modulators -- adverse effects
- Tamoxifen -- adverse effects
- Trastuzumab
No physical items for this record
Publication Type: Editorial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Comment
There are no comments on this title.
Log in to your account to post a comment.